No information is available on the use of resmetirom during breastfeeding. Because it is over 99% bound to plasma proteins, the amount is milk is likely to be very low. If a mother requires resmetirom, it is not a reason to discontinue breastfeeding. Until more data become available, resmetirom should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. Monitor the breastfed infant for vomiting, jaundice, fever, and rash.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Resmetirom
CAS Registry Number
920509-32-6
Drug Class
Breast Feeding
Lactation
Milk, Human
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
